×
  • Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor
    Hero Background

    Japan Safety Lancet Market

    ID: MRFR/HC/53171-HCR
    200 Pages
    Rahul Gotadki
    October 2025

    Japan Safety Lancet Market Research Report By Type (Push Button Safety Lancet, Pressure Activated Safety Lancet, Side Button Safety Lancet) and By End User (Hospitals & Clinics, Diagnostic Centers, Pathology Laboratories, Home Diagnostics, Other End Users)- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Japan Safety Lancet Market Infographic
    Purchase Options

    Japan Safety Lancet Market Summary

    The Japan Safety Lancet Market is projected to experience substantial growth from 121.1 million USD in 2024 to 456.9 million USD by 2035.

    Key Market Trends & Highlights

    Japan Safety Lancet Market Key Trends and Highlights

    • The market is expected to grow from 121.1 million USD in 2024 to 456.9 million USD by 2035.
    • A compound annual growth rate (CAGR) of 12.83 percent is anticipated from 2025 to 2035.
    • This growth trajectory indicates a robust demand for safety lancets in the Japanese healthcare sector.
    • Growing adoption of advanced safety lancet technologies due to increasing awareness of needle-stick injuries is a major market driver.

    Market Size & Forecast

    2024 Market Size 121.1 (USD Million)
    2035 Market Size 456.9 (USD Million)
    CAGR (2025-2035) 12.83%

    Major Players

    Sysmex Corporation, Abbott Laboratories, Thermo Fisher Scientific Inc., Terumo Corporation, Nipro Corporation, Merck KGaA, Johnson & Johnson, Becton, Dickinson, and Company, Roche Holding AG, B. Braun Melsungen AG, Medtronic Plc, Stryker Corporation, Fujifilm Holdings Corporation, Smiths Medical, Hitachi Ltd

    Japan Safety Lancet Market Trends

    The Japan Safety Lancet Market is experiencing important trends driven by various factors related to healthcare technology and patient safety. One of the key market drivers is the Japanese government's strong emphasis on improving healthcare quality and safety. With initiatives aimed at reducing needlestick injuries and enhancing patient outcomes, healthcare facilities are increasingly adopting safety lancets. This aligns with the country’s commitment to advance medical technologies and reduce healthcare costs, as highlighted in government health policies.

    In recent times, there has been a growing focus on preventive healthcare and regular blood testing, spurred by Japan’s aging population and the rising prevalence of chronic diseases such as diabetes.

    Developments in safety lancet usage are being favored by the new demographic trends, which create new possibilities for adopting easier and safer methods of blood sampling. At the same time, improvements in the design and usability of the lancets are increasing their attractiveness to healthcare workers and patients alike. Home-testing devices, together with safety lancets, are becoming more popular as one try to take control of managing their health. This indicates a change in cultural attitude towards self-monitoring.

    Moreover, partnerships between the healthcare providers and the manufacturers focus more on innovative product design for certain areas of the Japanese healthcare system.

    These trends signify the importance of creating strategic partnerships that focus on training and educating healthcare workers about the benefits of using safety lancets, thereby promoting their widespread acceptance and use. Overall, the Japan Safety Lancet Market is poised for growth, driven by regulatory support, technological advancements, and evolving patient care practices.

     

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Market Segment Insights

    Japan Safety Lancet Market Segment Insights

    Japan Safety Lancet Market Segment Insights

    Safety Lancet Market Type Insights

    Safety Lancet Market Type Insights

    The Japan Safety Lancet Market is characterized by its diverse Type segmentation, which plays a crucial role in catering to various medical and healthcare needs. The Push Button Safety Lancet is designed to provide a simplified user experience, allowing for quick and efficient blood sample collection, which is particularly beneficial for point-of-care testing. This ease of use is appealing to both healthcare professionals and patients, as it minimizes discomfort and reduces the chances of user error.

    On the other hand, the Pressure Activated Safety Lancet employs a mechanism that activates upon applying a specific pressure, making it an optimal choice for controlled lancing, which can be crucial in minimizing pain, especially for frequent users such as diabetics.This innovative approach enhances patient trust and compliance in their healthcare routines. 

    Safety Lancet Market End User Insights

    Safety Lancet Market End User Insights

    The Japan Safety Lancet Market focused on the End User segment, showcases a diverse application landscape that reflects the country's advanced healthcare system. Hospitals and clinics play a crucial role in this market, as they require efficient devices for patient care and routine testing. The presence of numerous diagnostic centers in Japan underscores the growing demand for safety lancets to ensure accurate blood sampling and minimize the risk of needle-stick injuries among healthcare professionals. 

    Similarly, pathology laboratories are vital as they rely on innovative devices for precise diagnostics, thus ensuring that patients receive timely and effective treatment.Home diagnostics is gaining traction in Japan, driven by the increasing awareness of personal health monitoring, empowering individuals to manage their health proactively. 

    Get more detailed insights about Japan Safety Lancet Market

    Key Players and Competitive Insights

    The Japan Safety Lancet Market has been gaining significant traction in recent years, driven by the growing emphasis on patient safety, increasing awareness about the importance of proper medication administration, and a rising prevalence of chronic diseases requiring regular blood sampling. The competitive landscape is characterized by a blend of established players and emerging companies, all vying for market share through innovative product offerings and advancements in technology. 

    The market is influenced by various factors, including regulatory frameworks, healthcare infrastructure, and the overall demand for medical devices that enhance the safety and efficacy of clinical procedures. Understanding the competitive insights in this market segment reveals the strategic priorities of key players and their approach to leveraging technology and research for product development.Sysmex Corporation is a prominent player within the Japan Safety Lancet Market, recognized for its robust experience and expertise in the medical device sector, particularly in the field of diagnostic testing.

    The company’s strengths lie in its strong focus on research and development, resulting in the introduction of innovative lancet solutions that enhance safety during blood sampling procedures. 

    Sysmex Corporation maintains a significant market presence due to its established distribution networks and partnerships with local healthcare providers, enabling it to deliver products that meet the specific safety needs of the Japanese market. The company’s commitment to quality and its track record of reliability has cemented its reputation as a trusted choice among healthcare professionals.Abbott Laboratories holds a competitive position in the Japan Safety Lancet Market through its diverse portfolio of medical products, including advanced diagnostic devices that facilitate safe blood collection.

    The company is recognized for its innovations in healthcare technologies, which are designed to enhance the user experience and improve patient outcomes. 

    Abbott Laboratories emphasizes its strengths in market presence, thanks to its extensive distribution channels and strong relationships with healthcare institutions across Japan. The company actively pursues strategic collaborations and acquisitions to enhance its product offerings and expand its reach within the healthcare ecosystem. By focusing on specific needs within the Japanese healthcare market, Abbott Laboratories can effectively cater to local preferences while remaining at the forefront of safety and quality standards in its lancet products.

    Key Companies in the Japan Safety Lancet Market market include

    Industry Developments

    Recent developments in the Japan Safety Lancet Market are notable, highlighting the ongoing innovations and shifts within the sector. Sysmex Corporation continues to expand its portfolio of diagnostic solutions while engaging in research initiatives aimed at enhancing the precision of healthcare delivery. Abbott Laboratories has made strides in launching new blood collection devices, focusing on user safety and comfort. In August 2023, Thermo Fisher Scientific Inc. announced an investment in a new manufacturing facility in Japan to meet the growing demand for laboratory equipment, further expanding its operational footprint.

    Moreover, Terumo Corporation is actively participating in partnerships aimed at improving device technologies for better patient care. 

    In terms of mergers and acquisitions, Johnson and Johnson's acquisition of a Japanese biotech firm in September 2023 aims to bolster its product pipeline. Recent market trends indicate a growing demand for safety lancets among healthcare providers due to the heightened focus on patient safety and the implementation of stringent regulatory standards in Japan. This focus on enhancing device safety and usability has spurred an increase in market valuation, emphasizing the importance of innovation in maintaining competitive advantage and meeting changing healthcare needs.

     

    Future Outlook

    Japan Safety Lancet Market Future Outlook

    Market Segmentation

    Outlook

    • Hospitals & Clinics
    • Diagnostic Centers
    • Pathology Laboratories
    • Home Diagnostics
    • Other End Users

    Report Scope

    Report Attribute/Metric Source:Details
    MARKET SIZE 2023108.38(USD Million)
    MARKET SIZE 2024121.12(USD Million)
    MARKET SIZE 2035456.86(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR)12.827% (2025 - 2035)
    REPORT COVERAGERevenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR2024
    MARKET FORECAST PERIOD2025 - 2035
    HISTORICAL DATA2019 - 2024
    MARKET FORECAST UNITSUSD Million
    KEY COMPANIES PROFILEDSysmex Corporation, Abbott Laboratories, Thermo Fisher Scientific Inc., Terumo Corporation, Nipro Corporation, Merck KGaA, Johnson & Johnson, Becton, Dickinson and Company, Roche Holding AG, B. Braun Melsungen AG, Medtronic Plc, Stryker Corporation, Fujifilm Holdings Corporation, Smiths Medical, Hitachi Ltd
    SEGMENTS COVEREDType, End User
    KEY MARKET OPPORTUNITIESIncreasing diabetes prevalence, Expanding home healthcare services, Rising demand for preventive healthcare, Technological advancements in devices, Government initiatives for safe devices
    KEY MARKET DYNAMICSregulatory compliance demands, growing diabetic population, technological advancements in design, increasing awareness of safety, rising prevalence of infectious diseases
    COUNTRIES COVEREDJapan

    Leave a Comment

    FAQs

    What is the projected market size of the Japan Safety Lancet Market by 2035?

    The Japan Safety Lancet Market is expected to reach a value of 456.86 million USD by 2035.

    What was the market value of the Japan Safety Lancet Market in 2024?

    In 2024, the Japan Safety Lancet Market is valued at 121.12 million USD.

    What is the expected CAGR for the Japan Safety Lancet Market from 2025 to 2035?

    The expected CAGR for the Japan Safety Lancet Market from 2025 to 2035 is 12.827%.

    Which type of safety lancet is projected to lead the market in 2035?

    The Push Button Safety Lancet is projected to lead the market with an expected value of 150.0 million USD in 2035.

    What is the market size for Pressure Activated Safety Lancet by 2035?

    The market for Pressure Activated Safety Lancet is anticipated to reach 120.0 million USD by 2035.

    What is the expected market size for Side Button Safety Lancet in 2035?

    By 2035, the Side Button Safety Lancet market is expected to grow to 186.86 million USD.

    Who are the major players in the Japan Safety Lancet Market?

    Major players in the market include Sysmex Corporation, Abbott Laboratories, and Thermo Fisher Scientific Inc.

    What growth opportunities can be anticipated in the Japan Safety Lancet Market?

    The growth opportunities include increasing demand for safer medical devices and advances in technology.

    What challenges does the Japan Safety Lancet Market face?

    Challenges include regulatory compliance and competition from alternative technologies.

    How is the current global scenario impacting the Japan Safety Lancet Market?

    The current global scenario is expected to influence supply chains and market dynamics in the Japan Safety Lancet Market.

    Download Free Sample

    Kindly complete the form below to receive a free sample of this Report

    Case Study
    Chemicals and Materials

    Compare Licence

    ×
    Features License Type
    Single User Multiuser License Enterprise User
    Price $4,950 $5,950 $7,250
    Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
    Free Customization
    Direct Access to Analyst
    Deliverable Format
    Platform Access
    Discount on Next Purchase 10% 15% 15%
    Printable Versions